Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(2,6-dimethylphenyl)-3-methylamidinourea
2. Lidamidine, Hydrochloride
3. Lidamidine, Monohydrochloride
4. Whr-1142a
1. 66871-56-5
2. Lidamidine [inn]
3. N-(2,6-dimethylphenyl)-n'-(imino(methylamino)methyl)urea
4. 1-(2,6-dimethylphenyl)-3-(n'-methylcarbamimidoyl)urea
5. 2-[({[imino(methylamino)methyl]amino}carbonyl)amino]-1,3-dimethylbenzene
6. Lidamidine (inn)
7. 1-(2,6-dimethylphenyl)-3-(n-methylcarbamimidoyl)urea
8. Q8x04w8418
9. Ncgc00160661-01
10. Urea, N-(2,6-dimethylphenyl)-n'-(imino(methylamino)methyl)-
11. Dsstox_cid_29006
12. Dsstox_rid_83271
13. Dsstox_gsid_49080
14. Lidamidina
15. Lidamidinum
16. Urea, N-(2,6-dimethylphenyl)-n'-[imino(methylamino)methyl]-
17. Urea,n-(2,6-dimethylphenyl)-n'-[imino(methylamino)methyl]-
18. Lidamidinum [inn-latin]
19. Lidamidina [inn-spanish]
20. Cas-66871-56-5
21. Unii-q8x04w8418
22. Lidamidine [mi]
23. Timtec1_004303
24. Lidamidine [who-dd]
25. Schembl122710
26. Chembl448416
27. Dtxsid4049080
28. Chebi:134907
29. Hms1546d13
30. Tox21_113641
31. Mfcd00449519
32. Stk095480
33. Zinc13115357
34. Akos001737102
35. Tox21_113641_1
36. Ms-3109
37. Ncgc00160661-02
38. 1-(2',6'-dimethylphenyl)-3-methylamidinourea
39. 1-(methylamidino)-3-(2,6-xylyl)urea
40. D08126
41. 1-(2', 6'-dimethylphenyl)-3-methylamidinourea
42. Sr-01000308723
43. Sr-01000308723-1
44. Brd-k68693535-001-01-8
45. Q27287122
46. Urea, 1-(2,6-dimethyl)phenyl-3-(n-methylamidino)-
| Molecular Weight | 220.27 g/mol |
|---|---|
| Molecular Formula | C11H16N4O |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 220.13241115 g/mol |
| Monoisotopic Mass | 220.13241115 g/mol |
| Topological Polar Surface Area | 79.5 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 267 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidiarrheals
Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (See all compounds classified as Antidiarrheals.)
Adrenergic Agonists
Drugs that bind to and activate adrenergic receptors. (See all compounds classified as Adrenergic Agonists.)
ABOUT THIS PAGE
64
PharmaCompass offers a list of Lidamidine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lidamidine Hydrochloride manufacturer or Lidamidine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lidamidine Hydrochloride manufacturer or Lidamidine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Lidamidine Hydrochloride API Price utilized in the formulation of products. Lidamidine Hydrochloride API Price is not always fixed or binding as the Lidamidine Hydrochloride Price is obtained through a variety of data sources. The Lidamidine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_29006 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_29006, including repackagers and relabelers. The FDA regulates DSSTox_CID_29006 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_29006 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_29006 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_29006 supplier is an individual or a company that provides DSSTox_CID_29006 active pharmaceutical ingredient (API) or DSSTox_CID_29006 finished formulations upon request. The DSSTox_CID_29006 suppliers may include DSSTox_CID_29006 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_29006 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
DSSTox_CID_29006 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_29006 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_29006 GMP manufacturer or DSSTox_CID_29006 GMP API supplier for your needs.
A DSSTox_CID_29006 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_29006's compliance with DSSTox_CID_29006 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_29006 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_29006 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_29006 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_29006 EP), DSSTox_CID_29006 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_29006 USP).
